Aspen Pharmacare Holdings Ltd. (ASPEN) JSE:APN share price - Click a Company

The latest financial information on the JSE listed company Aspen Pharmacare Holdings Ltd. (APN), including the stock price, historical share price performance charts, annual reports, market cap, consensus forecast and dividends.

JUMP TO: Sens Information Directors' Dealings List funds

/

Open:
Prev close:
Range:
Volume:
Ave trading volume:

Bid:
Bid volume:
Offer:
Offer volume:

52 week range:

Click and drag to zoom in on timeline.

	Intraday
	7 days
	30 days
	90 days
	6 months
	1 year
	YTD
	3 years
	5 years
	10 years
Graphs are updated every 5 minutes between 09:05 and 17:05 on weekdays. Move %s are calculated on the previous close price.

Compare

Indices

This consensus forecast was last updated on 2024/09/09

Consensus forecasts are supplied by third party analysts and calculated by our data feed providers. As the forecast is completely dependent on updates received, not all companies' consensus forecasts are updated regularly.

Market cap:	76,643,838,021
EPS - TTM:	1356.64
P/E ratio:	12.66
Forward P/E:	8.62
Dividend yield:	2.09 %
Return on equity:	5.19 %
Return on assets:	8.49 %
Net asset value:	19,016.37
Price/NAV:	0.90
Authorised shares:	717,600,000
Issued shares:	446,252,332

Price data is updated daily.

Report	Date
APN - Annual Report June 2024	2024/06/30
APN - Annual Report June 2023	2023/06/30
APN - Annual Report June 2022	2022/06/30
APN - Annual Report June 2021	2021/06/30
APN - Annual Report June 2020 - Part 1	2020/06/30
APN - Annual Report June 2020 - Part 2	2020/06/30

Obesity drugs market could grow to $100bn by 2030

24 Oct 2024 1

Which companies are benefitting from the stronger rand?

15 Oct 2024

Transaction costs, China procurement knock Aspen’s earnings

3 Sep 2024

All you need is love, but lower interest rates would help

3 Sep 2024

Volgende jaar gaan ons geen “want…” hoor nie

3 Sep 2024

Adcock Ingram ups Heps and dividend by 10%

UPDATE

22 Aug 2024

12.11.24 12:00

ASPEN PHARMACARE HOLDINGS LIMITED – Broad-Based Black Economic Empowerment Annual Compliance Report for the year ended 30 June 2024

25.10.24 17:00

ASPEN PHARMACARE HOLDINGS LIMITED – Availability of Integrated Report, B-BBEE Verification Certificate and further Notice of Annual General Meeting

14.10.24 17:00

ASPEN PHARMACARE HOLDINGS LIMITED – Granting of Securities to Directors, Prescribed Officers and the Company Secretary of the Company

07.10.24 16:02

ASPEN PHARMACARE HOLDINGS LIMITED – Dealing in Securities by Directors, Prescribed Officers and the Company Secretary

02.10.24 12:00

ASPEN PHARMACARE HOLDINGS LIMITED – No Change Statement, availability of Audited Annual Financial Statements and Notice of Annual General Meeting

23.09.24 12:00

ASPEN PHARMACARE HOLDINGS LIMITED – Dealing in Securities by Director of the Company

03.09.24 13:47

ASPEN PHARMACARE HOLDINGS LIMITED – Condensed Group Financial Results for the Year Ended 30 June 2024 and Cash Dividend Declaration

19.08.24 09:00

ASPEN PHARMACARE HOLDINGS LIMITED – Reminder of release of Annual Financial Results for the Year Ended 30 June 2024 and a Live Presentation thereof

08.07.24 17:16

ASPEN PHARMACARE HOLDINGS LIMITED – Correction Announcement: Notice of Availability of Results Presentation

08.07.24 12:00

ASPEN PHARMACARE HOLDINGS LIMITED – Notice regarding the release of Aspen’s Financial Results for the year ending 30 June 2024, and Results Presentation

Sector: Pharmaceuticals and Biotechnology

Company / Share

Price / Move

NUMERAL

ASCENDIS

ASPEN

ADCOCK

'000 Rands	Jun 24 F	Dec 23 I
Turnover	44,706	21,141
Op Inc Operating Income	6,998	3,500
Att Inc Income Attributable To Equity Holders	4,404	2,314
Cash Gen PS Cash Generated Per Share	1394.95	553.23
Cshflo frm ops Net Cash flow from operating activities	6,225	2,458
Oper Pft Mgn Operating Profit Margin	15.65 %	16.56 %

'000 Rands	Jun 24 F	Dec 23 I
Fixed Ass Fixed Assets	19,946,000	19,237,000
Tot Curr Ass Total Current Assets	44,086,000	44,017,000
Ord SH Int Ordinary Shareholders' Interest	84,861,000	85,600,000
	0	0
LT Liab Total Long-Term Liabilities	29,914,000	30,748,000
Tot Curr Liab Total Current Liabilities	24,380,000	22,944,000

	Jun 24 F	Dec 23 I
EPS (ZARc) Earnings Per Share (ZARc)	991.4	520.8
HEPS-C (ZARc)	1356.6	620.7
DPS (ZARc) Distributions Per Share (ZARc)	359	0
NAV PS (ZARc) Net Asset Value Per Share (ZARc)	19016.37	19266.26
Ret on SH Fnd Return on Shareholder Funds	5.19 %	5.41 %
Ret On Tot Ass Return on Total Assets	8.49 %	8.86 %

Next AGM date: Thursday, 5 December 2024, confirmed
Interim results estimated to be released on 4 March 2025

Here is a list of South African unit trusts holding this share. These tables reflect changes in holdings over two quarters, but do not show where a fund has completely sold a holding during the latest quarter.

Holdings	Jun 2024		Mar 2024		Unit change	Value change (R'000s)	% of Fund	manco	link	code
Holdings	# Units	Value (R'000s)	# Units	Value (R'000s)	Unit change	Value change (R'000s)	% of Fund	manco	link	code
10X Moderate Fund	57,373	133,856.950	43,506	95,443.460	13,867	38,413.490	0.4740	Fund managed by 10X Index Fund Managers (RF) Pty Ltd.	10X Medium Equity Index Fund (A) - 10XMA 10X Medium Equity Index Fund (P) - 10XMP 10X Medium Equity Index Fund (T) - 10XMT	10x-moderate-fund
10X S&P SA Top 50 ETF	123,967	289,227.410	116,922	256,503.480	7,045	32,723.930	1.6214	Fund managed by 10X Index Fund Managers (RF) Pty Ltd.	CoreShares Top 50 ETF () - CTOP50	10x-sp-sa-top-50-etf
10X Stable Income Fund	300	699.930	0	0.000	300	699.930	0.2183	Fund managed by 10X Index Fund Managers (RF) Pty Ltd.	CoreShares Stable Income Fund (A) - CSTIA	10x-stable-income-fund
10X Top 60 SA Equity Index Fund	102,308	238,694.790	85,906	188,460.580	16,402	50,234.210	1.7231	Fund managed by 10X Index Fund Managers (RF) Pty Ltd.	10X Top 60 SA Equity Index Fund (A) - 10X60A 10X Top 60 SA Equity Index Fund (B) - 10X60B 10X Top 60 SA Equity Index Fund (C) - 10X60C 10X Top 60 SA Equity Index Fund (P) - 10X60P 10X Top 60 SA Equity Index Fund (T) - 10X60T	10x-top-60-sa-equity-index-fund
10X Wealth Accumulation Fund	8,417	19,637.700	9,354	20,520.810	-937	-883.110	0.7686	Fund managed by 10X Index Fund Managers (RF) Pty Ltd.	CoreShares Wealth Accumulation Fund (A) - CSWACA	10x-wealth-accumulation-fund
Total

The free version only lists 5 unit trusts. Subscribe to see the full list.

SUBSCRIBE NOW

Share	Declared date	Last day to trade	Pay date	Type	Value
ASPEN	2024/09/03	2024/09/17	2024/09/23	Final	359 ZARc

Date

Beneficiary

Deal Type

Value

Volume

Price

2024/05/23

Capazorio, Sean

Sell (SENS)

3,649,164

15,868

229.97

2019/11/12

Company Secretary

Sell (SENS)

106,237

907

117.13

2018/12/03

Company Secretary

Sell (SENS)

156,641

1,051

149.04

2018/10/19

Attridge, Michael Guy

Buy (SENS)

15,646,000

100,000

156.46

2018/10/19

Saad, Stephen B

Buy (SENS)

93,876,000

600,000

156.46

2018/09/17

Company Secretary

Buy (SENS)

39,948

203

196.79

2018/09/14

Mortimer, Christopher N

Buy (SENS)

2,050,000

10,000

205.00

2017/11/17

Company Secretary

Sell (SENS)

207,224

667

310.68

2017/11/06

Company Secretary

Sell (SENS)

170,283

544

313.02

2016/11/02

Company Secretary

Sell (SENS)

244,440

840

291.00

Nature of business
Aspen is a global specialty and branded pharmaceutical company, improving the health of patients across the world through its high quality and affordable medicines. Active at every stage of the value chain, the Group is uniquely diversified by geography, product, and manufacturing capability.

Company email
[email protected]

Company website
http://www.aspenpharma.com

Transfer secretary
JSE Investor Services (Pty) Ltd.

Company secretary
Raeesa Khan

Postal address
PO Box 1587, Gallo Manor, 2052

Registered address
Building no 8, Healthcare Park, Woodlands Drive, Woodmead, Sandton, 2196

Company tel
011 239-6100

Company fax
011 239-6144

Major shareholders
Government Employees Pension Fund, Saad, SB, Attridge, MG, Ceppawu Iinvestments (Pty) Ltd., GIC Asset Management Pte Ltd., Vanguard Total International Stock Index, Foord Balanced Fund, SAFE Investment Company Ltd., Old Mutual Life Assurance Co Ltd, Vanguard Emerging Market Stock Index Fund (US)

This consensus forecast was last updated on 2024/09/09

Market cap:	76,643,838,021
EPS - TTM:	1356.64
P/E ratio:	12.66
Forward P/E:	8.62
Dividend yield:	2.09 %
Return on equity:	5.19 %
Return on assets:	8.49 %
Net asset value:	19,016.37
Price/NAV:	0.90
Authorised shares:	717,600,000
Issued shares:	446,252,332

Price data is updated daily.

Report	Date
APN - Annual Report June 2024	2024/06/30
APN - Annual Report June 2023	2023/06/30
APN - Annual Report June 2022	2022/06/30
APN - Annual Report June 2021	2021/06/30
APN - Annual Report June 2020 - Part 1	2020/06/30
APN - Annual Report June 2020 - Part 2	2020/06/30